Meeting
2012 Genitourinary Cancers Symposium
A population-based overview of sequences of targeted therapy in metastatic renal cell carcinoma (mRCC).
Authors
Daniel Yick Chin Heng
Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada
Daniel Yick Chin Heng , Jae-Lyun Lee , Lauren Christine Harshman , Georg A. Bjarnason , Albiruni R Razak , Mary J. MacKenzie , Lori Wood , Ulka N. Vaishampayan , Min-Han Tan , Sun Young Rha , Frede Donskov , Neeraj Agarwal , Christian K. Kollmannsberger , Scott A. North , Brian I. Rini , Toni K. Choueiri
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session E: Renal Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 30, 2012 (suppl 5; abstr 387)
DOI
10.1200/jco.2012.30.5_suppl.387
Abstract #
387
Poster Bd #
C10
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Association of high cost sharing and target therapy initiation among Medicare patients with metastatic renal cell carcinoma.
First Author: Pengxiang Li
Poster
2015 Genitourinary Cancers Symposium
Third-line therapy in metastatic renal cell carcinoma: Results from the International mRCC Database Consortium.
First Author: Daniel Yick Chin Heng
Poster
2014 ASCO Quality Care Symposium
Reporting on quality indicators in renal cell carcinoma: Proportion of metastatic patients who initially commence on full-dose targeted therapy.
First Author: Lori Wood
Poster
2014 Genitourinary Cancers Symposium
Duration of targeted therapy in metastatic renal cell carcinoma patients with ECOG PS>2.
First Author: Ilya Tsimafeyeu